These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35204677)

  • 1. Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes.
    Salvatore T; Galiero R; Caturano A; Vetrano E; Rinaldi L; Coviello F; Di Martino A; Albanese G; Colantuoni S; Medicamento G; Marfella R; Sardu C; Sasso FC
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction-A Specific HFpEF Phenotype.
    Elsanhoury A; Nelki V; Kelle S; Van Linthout S; Tschöpe C
    Front Cardiovasc Med; 2021; 8():720690. PubMed ID: 34604353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart failure with preserved ejection fraction as a model disease for the cardio-pulmonary-renal syndrome : Importance of visceral fat expansion as central pathomechanism].
    Tschöpe C; Elsanhoury A; Nelki V; Van Linthout S; Kelle S; Remppis A
    Internist (Berl); 2021 Nov; 62(11):1141-1152. PubMed ID: 34613426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus.
    Shi YJ; Dong GJ; Guo M
    World J Diabetes; 2023 Jun; 14(6):724-740. PubMed ID: 37383601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes.
    Packer M
    JACC Heart Fail; 2021 Aug; 9(8):535-549. PubMed ID: 34325884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target.
    Rossi VA; Gruebler M; Monzo L; Galluzzo A; Beltrami M
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
    Anker SD; Butler J; Filippatos GS; Jamal W; Salsali A; Schnee J; Kimura K; Zeller C; George J; Brueckmann M; Zannad F; Packer M;
    Eur J Heart Fail; 2019 Oct; 21(10):1279-1287. PubMed ID: 31523904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial Adipose Tissue and Heart Failure, Friend or Foe?
    Cho DH; Park SM
    Diabetes Metab J; 2024 May; 48(3):373-384. PubMed ID: 38310880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
    Khan MS; Fonarow GC; McGuire DK; Hernandez AF; Vaduganathan M; Rosenstock J; Handelsman Y; Verma S; Anker SD; McMurray JJV; Kosiborod MN; Butler J
    Circulation; 2020 Sep; 142(12):1205-1218. PubMed ID: 32955939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial adipose tissue in obesity-related cardiac dysfunction.
    Ayton SL; Gulsin GS; McCann GP; Moss AJ
    Heart; 2022 Mar; 108(5):339-344. PubMed ID: 33985985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target.
    Timóteo AT; Barbas Albuquerque F; Lacerda Teixeira B
    Int J Cardiol; 2024 Oct; 412():132303. PubMed ID: 38944349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection Fraction.
    Palaguachi GI; Frishman W
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):274-278. PubMed ID: 34132654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
    van Woerden G; Gorter TM; Westenbrink BD; Willems TP; van Veldhuisen DJ; Rienstra M
    Eur J Heart Fail; 2018 Nov; 20(11):1559-1566. PubMed ID: 30070041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.
    Packer M
    Cardiovasc Diabetol; 2019 Sep; 18(1):121. PubMed ID: 31551089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure.
    Pérez-Belmonte LM; Moreno-Santos I; Gómez-Doblas JJ; García-Pinilla JM; Morcillo-Hidalgo L; Garrido-Sánchez L; Santiago-Fernández C; Crespo-Leiro MG; Carrasco-Chinchilla F; Sánchez-Fernández PL; de Teresa-Galván E; Jiménez-Navarro M
    Int J Med Sci; 2017; 14(9):891-895. PubMed ID: 28824327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction.
    Koepp KE; Obokata M; Reddy YNV; Olson TP; Borlaug BA
    JACC Heart Fail; 2020 Aug; 8(8):657-666. PubMed ID: 32653449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure.
    Pugliese NR; Paneni F; Mazzola M; De Biase N; Del Punta L; Gargani L; Mengozzi A; Virdis A; Nesti L; Taddei S; Flammer A; Borlaug BA; Ruschitzka F; Masi S
    Eur J Heart Fail; 2021 Nov; 23(11):1858-1871. PubMed ID: 34427016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.